Denis Raccah
Marseille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Retraction Note: Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii.
Journal: International journal of obesity (2005)
Published: July 29, 2024
Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study §.
Journal: Sensors (Basel, Switzerland)
Published: July 26, 2021
Reply to Letter by Alexander Seibold on "Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring Systems in a Type 1 Diabetes Patient French Cohort: An Observational Study of Clinical Practices" by Yannis Préau, et al. (doi: 10.1089/dia.2020.0674).
Journal: Diabetes technology & therapeutics
Published: February 26, 2021
Impact of Switching from Intermittently Scanned to Real-Time Continuous Glucose Monitoring Systems in a Type 1 Diabetes Patient French Cohort: An Observational Study of Clinical Practices.
Journal: Diabetes technology & therapeutics
Published: November 02, 2020
Fixed-Ratio Combination of Insulin and GLP-1 RA in Patients with Longstanding Type 2 Diabetes: A Subanalysis of LixiLan-L.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: January 27, 2020
Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial.
Journal: The Lancet. Digital health
Published: January 30, 2019
Clinical implications of prolonged hyperglycaemia before basal insulin initiation in type 2 diabetes patients: An electronic medical record database analysis.
Journal: Endocrinology, diabetes & metabolism
Published: December 17, 2018
Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: January 23, 2018
Review of basal-plus insulin regimen options for simpler insulin intensification in people with Type 2 diabetes mellitus.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: May 30, 2017
Safety and tolerability of glucagon-like peptide-1 receptor agonists: unresolved and emerging issues.
Journal: Expert opinion on drug safety
Published: December 08, 2016
Individualized, patient-centered use of lixisenatide for the treatment of type 2 diabetes mellitus.
Journal: Expert opinion on drug metabolism & toxicology
Published: November 04, 2016
Differential effects of glucagon-like peptide-1 receptor agonists on heart rate.
Journal: Cardiovascular diabetology
Published: September 23, 2016
Last Updated: 09/26/2026